Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Extensive Small Cell Lung Cancer × Etoposide × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 124 Lymphoma, Large B-Cell, Diffuse 77 Lymphoma, Non-Hodgkin 75 Small Cell Lung Carcinoma 70 Hodgkin Disease 57 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Leukemia 53 Burkitt Lymphoma 52 Lung Neoplasms 46 Lymphoma, Follicular 43 Lymphoma, Mantle-Cell 39 Lymphoma, Large-Cell, Immunoblastic 38 Leukemia, Myeloid, Acute 37 Leukemia, Lymphocytic, Chronic, B-Cell 33 Multiple Myeloma 29 Carcinoma, Non-Small-Cell Lung 26 Recurrence 24 Lymphoma, B-Cell, Marginal Zone 24 Neuroblastoma 21 Central Nervous System Neoplasms 20 Ovarian Neoplasms 17 Sarcoma 16 Dendritic Cell Sarcoma, Interdigitating 16 Congenital Abnormalities 15 Breast Neoplasms 15 Brain Neoplasms 15 Neoplasms, Plasma Cell 14 Myelodysplastic Syndromes 13 Lymphoma, Large-Cell, Anaplastic 13 Neoplasms 12

Interventions

Radiotherapy 1 Etoposide 1 Drug Therapy 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07083375 2025-07-24

QL1706

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Extensive Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡